- Home
- ALLO vs ATNI Comparison
ALLO vs ATNI Comparison
Compare ALLO & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | ATNI |
|---|---|---|
| Founded | 2017 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.7M | 482.0M |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ALLO | ATNI |
|---|---|---|
| Price | $1.69 | $28.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $8.35 | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 66.7K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.03% |
| EPS Growth | 34.09 | ★ 34.29 |
| EPS | N/A | ★ 10.44 |
| Revenue | N/A | ★ $727,975,000.00 |
| Revenue This Year | N/A | $3.12 |
| Revenue Next Year | $142,416.42 | $1.10 |
| P/E Ratio | ★ N/A | $2.79 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.04 | $13.86 |
| 52 Week High | $4.46 | $33.41 |
Technical Indicators
Market Signals| Indicator | ALLO | ATNI |
|---|---|---|
| Relative Strength Index (RSI) | 35.42 | 39.76 |
| Support Level | $1.59 | $25.03 |
| Resistance Level | $1.92 | $29.28 |
| Average True Range (ATR) | 0.08 | 0.84 |
| MACD | -0.03 | -0.36 |
| Stochastic Oscillator | 6.58 | 8.70 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.